Innovative X-Ray machine manufacturer Micro-X has moved closer to launching the militarised version of its Nano machine following the completion of compliance testing. The Adelaide company said today it had successfully completed the electrical and mechanical safety test programme for its new Rover X-Ray machine (pictured), the final requirement before applying for US Food and…
There is no doubt that COVID-19 has plunged our country, and the world, into economic chaos. The impact of the virus has truly challenged the old order and we are being forced to decide what we want the future of Australian manufacturing to look like.
As the fourth largest industry in Australia, manufacturing is critical to rebuilding the health of our economy.
Industry Minister Karen Andrews has recently stated that although COVID-19 highlighted a number of serious sovereign capability gaps, total domestic self-sufficiency shouldn’t be the goal for our future. I agree and believe instead we must mature those niche opportunities that draw on Australia’s own resources and R&D strengths and focus on the manufacturing and broader industrial races we can win, both locally and globally.
Overall manufacturing activity was up slightly in May compared to April, but remains in “deep contraction” according to the Australian Industry Group’s Performance of Manufacturing Index.
Last week Brisbane medtech company Vaxxas, which is trying to reinvent the needle, announced plans to move to industrial-scale production. Brent Balinski spoke to the company’s Dr Angus Forster about getting from invention to impact.
The @AuManufacturing new deal plan for manufacturing, crowd sourced from readers and members of the Australian Manufacturing Forum LInkedin group, is released today after two months work. Here we present the plan’s executive summary and core recommendations. The full plan may be downloaded here. After close to three decades of economic growth Australia’s luck has…
Listed food manufacturer Longtable, which makes the Maggie Beer range of luxury products, has stepped up its online business as Covid-19 lockdowns and restaurant closures affected sales growth, with the downturn especially apparent in April. The Barossa Valley company told investors that its St David Dairy and Paris Creek dairy businesses had been hit by…
Biotechnology giant CSL has announced the outsourcing of operations in its latest new manufacturing facility now nearing completion in Lengnau, Switzerland. The Melbourne company told investors that after a strategic review it had entered a long term strategic partnership with science service provider Thermo Fisher Scientific to lease its new state of the art biotech…
